Association of Monocyte Chemoattractant Protein-1 −2518 Polymorphism With Metabolic Syndrome in a South Indian Cohort

Abstract

Background:

Previous reports have indicated an association of monocyte chemoattractant protein-1 (MCP-1) with risk factors for atherosclerosis and coronary artery disease (CAD). Because some of these risk factors form components of metabolic syndrome, in the present study, we investigated the association of an important promoter region polymorphism of MCP-1, A–2518G, and its serum levels with metabolic syndrome in a South Indian cohort.

Methods:

The study comprised of 126 healthy subjects aged 30–59 years from South India. Subjects were classified on the basis of presence or absence of metabolic syndrome and metabolic syndrome components as per the International Diabetes Federation definition. MCP-1 genotyping was done by polymerase chain reaction restriction fragment-length polymorphism, and serum levels were estimated by enzyme-linked immunosorbent assay.

Results:

The MCP-1 –2518G allele frequency in the study population was 32.9% and the mean MCP-1 serum levels were 523 ± 272.3 pg/mL. Subjects with metabolic syndrome showed an increased presence of the MCP-1 –2518G allele in comparison to those without metabolic syndrome (odds ratio [OR] = 5.03, P = 0.02). The association was related to a higher proportion of this allele in subjects with increased waist circumference (OR = 3.78, P = 0.05).

Conclusions:

The MCP-1 –2518G allele may be contributing to atherosclerosis and CAD by conferring an increased risk to metabolic syndrome and/or obesity.